The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Acceleron Pharma Inc. | COM | 00434H108 | 10,403 | 278,753 | SH | SOLE | 278,753 | 0 | 0 | ||
Achaogen, Inc. | COM | 004449104 | 30,498 | 1,912,106 | SH | SOLE | 1,912,106 | 0 | 0 | ||
Aclaris Therapeutics, Inc. | COM | 00461U105 | 6,787 | 262,950 | SH | SOLE | 262,950 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 94,793 | 1,950,477 | SH | SOLE | 1,950,477 | 0 | 0 | ||
Aimmune Therapeutics, Inc. | COM | 00900T107 | 22,609 | 912,001 | SH | SOLE | 912,001 | 0 | 0 | ||
Alder BioPharmaceuticals, Inc. | COM | 014339105 | 36,042 | 2,942,203 | SH | SOLE | 2,942,203 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 3,991 | 176,500 | SH | SOLE | 176,500 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 10,336 | 285,143 | SH | SOLE | 285,143 | 0 | 0 | ||
Blueprint Medicines Corporation | COM | 09627Y109 | 32,583 | 467,682 | SH | SOLE | 467,682 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 4,836 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
Dermira, Inc. | COM | 24983L104 | 1,163 | 43,071 | SH | SOLE | 43,071 | 0 | 0 | ||
Epizyme, Inc. | COM | 29428V104 | 16,187 | 849,693 | SH | SOLE | 849,693 | 0 | 0 | ||
Immunomedics, Inc. | COM | 452907108 | 33,264 | 2,379,367 | SH | SOLE | 2,379,367 | 0 | 0 | ||
Loxo Oncology, Inc. | COM | 548862101 | 4,606 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 4,498 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Myokardia, Inc. | COM | 62857M105 | 12,641 | 295,000 | SH | SOLE | 295,000 | 0 | 0 | ||
Pacific Biosciences of California, Inc. | COM | 69404D108 | 6,038 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | ||
Tocagen, Inc. | COM | 888846102 | 3,653 | 293,177 | SH | SOLE | 293,177 | 0 | 0 | ||
Verona Pharma Plc | SPONSORED ADS | 925050106 | 9,346 | 608,851 | SH | SOLE | 608,851 | 0 | 0 | ||
WAVE Life Sciences Ltd. | SHS | Y95308105 | 18,777 | 863,327 | SH | SOLE | 863,327 | 0 | 0 |